The Journal of Immunology · 2002 · 199 citations · 34 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityVaccine ImmunologyVaccinologyAdjuvant DesignAdjuvant DevelopmentImmune Response To VaccinationInnate Immune ResponseMammalian ImmunologyVaccinationAdjuvant MechanismsAdjuvant-induced ImmunityCpg Motif EffectsImmunological AdjuvantsImmunostimulatory AdjuvantsIn Vivo StudiesLeishmaniasis PathogenesisVaccinal Adjuvants
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG ODN that stimulate human PBMC are only weakly active in mice. Thus, alternative animal models are needed to monitor the activity and safety of "human" CpG ODN in vivo. This work demonstrates that rhesus macaques recognize and respond to the same CpG motifs that trigger human immune cells. Coadministering CpG ODN with heat-killed Leishmania vaccine provided significantly increased protection of macaques against cutaneous Leishmania infection. These findings indicate that rhesus macaques provide a useful model for studying the in vivo activity of human CpG motifs, and that ODN expressing these motifs act as strong immune adjuvants.
34
A Toll-like receptor recognizes bacterial DNA
Hiroaki Hemmi, Osamu Takeuchi, Taro Kawai et al. · Nature · 2000 · 6.4K citations
CpG motifs in bacterial DNA trigger direct B-cell activation
Arthur Μ. Krieg, Ae‐Kyung Yi, Sara Matson et al. · Nature · 1995 · 3.5K citations